Insider Trading History of Nandabalan Krishnan

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Nandabalan Krishnan since year 2005. The trader's CIK number is 1733387. At the time of the last reporting, Nandabalan Krishnan was the Director of Bioxcel Therapeutics, Inc. . (stock ticker symbol BTAI). See this page for all insider trading activities at Bioxcel Therapeutics, Inc. .

Stock purchases, sales, and option exercises reported by insider Nandabalan Krishnan since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-11-29 BTAI Bioxcel Therapeutics, Inc. Buy 1,000 4.92 4,915

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nandabalan Krishnan (Director of Bioxcel Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.